Review

Nature Reviews Cancer 3, 807-820 (November 2003) | doi:10.1038/nrc1208

Cytostatic and apoptotic actions of TGF-bold beta in homeostasis and cancer

Peter M. Siegel1 & Joan Massagué1  About the authors

Top

The cytostatic and apoptotic functions of transforming growth factor-beta (TGF-beta) help restrain the growth of mammalian tissues; loss of these effects leads to hyperproliferative disorders and is common in cancer. However, tumour cells that are relieved from TGF-beta growth constraints might then overproduce this cytokine to create a local immunosuppressive environment that fosters tumour growth and exacerbates the invasive and metastatic behaviour of the tumour cells themselves. For these reasons, there is a growing interest in understanding and therapeutically targeting TGF-beta-mediated processes in cancer progression.

Author affiliations

  1. Cancer Biology and Genetics Program, Howard Hughes Medical Institute, Memorial Sloan–Kettering Cancer Center, New York, NY 10021, USA.

Correspondence to: Joan Massagué1 Email: j-massague@ski.mskcc.org

MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated

REFERENCE
Transforming Growth Factor beta (TGFβ)
Nature Encyclopaedia of Life Sciences
Bone Morphogenetic Proteins and their Receptors
Nature Encyclopaedia of Life Sciences

NEWS AND VIEWS
SMAD destruction turns off signalling
Nature Cell Biology News and Views (01 Dec 1999)
Quiescent T cells: actively maintaining inactivity
Nature Immunology News and Views (01 Dec 2001)
See all 5 matches for News And Views

RESEARCH
Blockade of Smad4 in transformed keratinocytes containing a Ras oncogene leads to hyperactivation of the Ras-dependent Erk signalling pathway associated with progression to undifferentiated carcinomas
Oncogene Original Article (24 Aug 2000)
See all 70 matches for Research

Extra navigation

Subscribe

Subscribe to Nature Reviews Cancer

Search PubMed for

naturejobs

Advertisement